Objective  To investigate the clinical efficacy of interesting respiratory rehabilitation training (IRRT) combined with budesonide and montelukast sodium in the treatment of  bronchial asthma (BA).

Methods  This is a pilot clinical research. Children with BA who visited Ma’anshan Shiqiye Hospital of Anhui province from January 2023 to December 2023 in were prospectively recruited as study subjects, and were divided into the IRRT group and the conventional group according to the random number table method. After 8 weeks of continuous intervention, the clinical efficacy, recovery of related symptoms and adverse reactions of BA children were evaluated. The changes in lung function parameters, inflammation indicators and quality of life were compared before and after treatment in the IRRT group and the conventional group, and the changes in lung function parameters, inflammation indicators and quality of life between the IRRT group and the conventional group after treatment were compared.

Results  A total of 120 BA children were included in the study, with 60 cases in each group. Before treatment, there was no significant difference in baseline data such as age and gender between the two groups (P>0.05). After 8 weeks of treatment, pulmonary function parameters, inflammation indicators, and quality of life were all improved in the IRRT group and the conventional group, (P<0.05), and the improvement in the IRRT group was better than that in the conventional group (P<0.05). In addition, the disappearance time of wheezing, disappearance time of cough, and disappearance time of dyspnea were significantly shorter than those in the conventional group (P<0.05). In terms of safety, no significant serious adverse effects were seen in the IRRT group and the conventional group.

Conclusion  Adjuvant IRRT therapy can significantly improve children's lung function, reduce the level of inflammatory factors, shorten the course of the disease, improve quality of life, and promote early recovery in children.

1.梁家浩, 杨舒龄, 王海. 基于孟德尔随机化探讨肠道菌群与儿童哮喘的因果关联[J]. 华西医学, 2024, 39(4): 553-560. [Liang JH, Yang SL, Wang H. Exploring the causal relationship between gut microbiota and childhood asthma based on Mendelian randomization[J]. West China Medical Journal, 2024, 39(4): 553-560.] DOI: 10.7507/1002-0179.202308103.

2.王薇, 何志伟, 范彦博, 等. 咳喘凝胶贴膏穴位敷贴对支气管哮喘大鼠炎症因子的影响[J]. 中国药师, 2022, 25(5): 812-815. [Wang W, He ZW, Fan YB, et al. Effect of acupoint application of Kechuan gel plaster on inflammatory factors in bronchial asthma rats[J]. China Herbalist, 2022, 25(5): 812-815.] DOI: 10.19962/j.cnki.issn1008-049X.2022.05.010.

3.涂彩霞, 李惠英, 张泉, 等. FCER2（rs28364072）多态性对吸入用布地奈德治疗儿童哮喘疗效的影响 [J]. 药物流行病学杂志, 2022, 31(6): 395-399. [Tu CX, Li HY, Zhang Q, et al. The effect of FCER2 (rs28364072) polymorphism on the efficacy of inhaled budesonide in the treatment of childhood asthma[J]. Chinese Journal of Pharmacoepidemiology, 2022, 31(6): 395-399.] DOI: 10.19960/j.cnki.issn1005-0698.2022.06.006.

4.马秋莉, 闫宇娇. 布地奈德+孟鲁司特钠在小儿咳嗽变异性哮喘治疗中的作用[J]. 数理医药学杂志, 2022, 35(12): 1762-1764. [Ma QL, Yan YJ. The role of budesonide and montelukast sodium in the treatment of cough variant asthma in children[J]. Journal of Mathematical Medicine, 2022, 35(12): 1762-1764.] DOI: 10.3969/j.issn.1004-4337.2022.12.006.

5.Ravi A, Goorsenberg AWM, Dijkhuis A, et al. Metabolic differences between bronchial epithelium from healthy individuals and patients with asthma and the effect of bronchial thermoplasty[J]. J Allergy Clin Immunol, 2021, 148(5): 1236-1248. DOI: 10.1016/j.jaci.2020.12.653.

6.张佳佳, 胡赤军, 周小勤, 等. 布地奈德联合孟鲁司特钠对支气管哮喘患儿细胞因子、免疫功能影响[J]. 现代生物医学进展, 2017, 17(3): 550-553. [Zhang JJ, Hu CJ, Zhou XQ, et al. Effect of budesonide combined with montelukast on cytokines and immune function in children with bronchial asthma[J]. Progress in Modern Biomedicine, 2017, 17(3): 550-553.] DOI: 10.13241/j.cnki.pmb.2017.03.040.

7.Jin W, Zhao Z, Zhou D. Effect of montelukast sodium combined with budesonide aerosol on airway function and T lymphocytes in asthmatic children[J]. Pak J Med Sci, 2022, 38(5): 1265-1270. DOI: 10.12669/pjms.38.5.5749.

8.Dai W, Zhen N, Qin X, et al. Effect of momethasone furoate combined with loratadine and montelukast sodium on inflammatory factors and pulmonary function in children with allergic rhinitis[J]. Am J Transl Res, 2022, 14(10): 7199-7207. https://pubmed.ncbi.nlm.nih.gov/36398245/.

9.钟晓梅, 万娟, 张莉, 等. 咳嗽变异性哮喘患儿血清sPD-L1、TLR4和sICAM-1水平及临床意义[J]. 西部医学, 2022, 34(10): 1512-1516. [Zhong XM, Wan J, Zhang L, et al. Serum levels of sPD-L1, TLR4, and sICAM-1 in children with cough variant asthma and their clinical significance[J]. Medical Journal of West China, 2022, 34(10): 1512-1516.] DOI: 10.3969/j.issn. 1672-3511.2022.10.021.

10.范新凤, 李艳玲, 孙晓宝, 等. 孟鲁司特钠咀嚼片联合布地奈德混悬液治疗急性期支气管哮喘患儿的临床研究[J]. 中国临床药理学杂志, 2023, 39(3): 320-323. [Fan XF, Li YL, Sun XB, et al. Clinical study on the treatment of children with acute bronchial asthma with montelukast chewable tablets combined with budesonide suspension[J]. The Chinese Journal of Clinical Pharmacology, 2023, 39(3): 320-323.] DOI: 10.13699/j. cnki.1001-6821.2023.03.004.

11.冷建刚, 杨泽民, 桑旭, 等. 吸入用布地奈德联合孟鲁司特钠、左西替利嗪治疗6~12岁小儿咳嗽变异性哮喘的临床疗效观察[J]. 蚌埠医学院学报, 2023, 48(4): 453-456. [Leng JG, Yang ZM, Sang X, et al. Clinical efficacy of inhaled budesonide combined with montelukast sodium and levocetirizine in the treatment of cough variant asthma in children aged6-12years old[J]. Journal of Bengbu Medical College, 2023, 48(4): 453-456.] DOI: 10.13898/j. cnki. issn.1000-2200.2023.04.008.

12.邓静, 黄静. 孟鲁司特钠联合布地奈德治疗小儿支气管哮喘的临床研究[J]. 中国临床药理学杂志, 2023, 39(14): 1983-1986. [Deng Jing, Huang Jing. Clinical study on montelukast combined with budesonide in the treatment of pediatric bronchial asthma[J]. The Chinese Journal of Clinical Pharmacology, 2023, 39(14): 1983-1986.] DOI: 10.13699/j. cnki.1001-6821.2023.14.002.

13.刘英丽, 徐梅佳, 吕伟, 等. 孟鲁司特钠联合布地奈德对哮喘患儿肺功能、炎症因子及免疫球蛋白水平的影响[J]. 海南医学院学报, 2017, 23(24): 3404-3407. [Liu  YL, Xu MJ, Lyu W, et al. Effect of montelukast combined with budesonide on lung function, inflammatory factors and immunoglobulin levels in children with asthma[J]. Journal of Hainan Medical University, 2017, 23(24): 3404-3407.] DOI: 10.13210/j. cnki. jhmu.20171208.006.

14.郑金荣. 西替利嗪联合布地奈德对支气管哮喘患儿气道重塑及免疫功能的影响[J]. 数理医药学杂志, 2022, 35(7): 1036-1038. [Zheng JR. The effect of cetirizine combined with budesonide on airway remodeling and immune function in children with bronchial asthma[J]. Journal of Mathematical Medicine, 2022, 35(7): 1036-1038.] DOI: 10.3969/j.issn.1004-4337.2022.07.028.

15.Chaves GSS, Freitas DA, Santino TA, et al. Chest physiotherapy for pneumonia in children[J]. Cochrane Db Syst Rev, 2019, 1(1): CD010277. DOI: 10.1002/14651858.CD010277.pub3.

16.中华医学会儿科学分会呼吸学组, 《中华儿科杂志》编辑委员会. 儿童支气管哮喘诊断与防治指南(2016 年版)[C]. 西安: 第二十次全国儿科中西医结合学术会议, 2016: 47-61.

17.Zhang Y, Li B. Effects of montelukast sodium plus budesonide on lung function, inflammatory factors, and immune levels in elderly patients with asthma[J]. Ir J Med Sci, 2020, 189(3): 985-990. DOI: 10.1007/s11845-019-02167-5.

18.Allam V, Paudel KR, Gupta G, et al. Nutraceuticals and mitochondrial oxidative stress: bridging the gap in the management of bronchial asthma[J]. Environ Sci Pollut Res Int, 2022, 29(42): 62733-62754. DOI: 10.1007/s11356-022-21454-w.

19.Diaz MA, Catalan-Caceres N, Beauperthuy TC, et al. Clinical features and outcomes associated with bronchial asthma among COVID-19hospitalizedpatients[J]. J Asthma Allergy, 2022, 15: 775-781. DOI: 10.2147/JAA.S354082.

20.Lee GKC, Beeler-Marfisi J, Viel L, et al. Bronchial brush cytology, endobronchial biopsy, and SALSA immunohistochemistry in severe equine asthma[J]. Vet Pathol, 2022, 59(1): 100-111. DOI: 10.1177/ 03009858211048635.

21.Feng KN, Meng P, Zou XL, et al. IL-37 protects against airway remodeling by reversing bronchial epithelial-mesenchymal transition via IL-24 signaling pathway in chronic asthma[J]. Respir Res, 2022, 23(1): 244. DOI: 10.1186/s12931-022-02167-7.

22.Chu FF, Liang L, Chen FZ, et al. Effect of budesonide combined with montelukast sodium on pulmonary function parameters and immunoglobulin levels in children with bronchial asthma[J]. Allergol Immunopathol (Madr), 2023, 51(4): 151-157. DOI: 10.15586/aei.v51i4.897.

23.王冰洁, 刘翔腾, 黄娟, 等. 西替利嗪联合布地奈德治疗小儿哮喘的临床效果[J]. 临床合理用药, 2024, 17(1): 116-119. [Wang BJ, Liu XT, Huang J, et al. Clinical efficacy of cetirizine combined with budesonide in the treatment of pediatric asthma[J]. Chinese Journal of Clinical Rational Drug Use, 2024, 17(1): 116-119.] DOI: 10.15887/j.cnki.13-1389/r.2024.01.031.

24.Ranjan OP, Kumar N, Dave V. Cross-linked alginate beads of montelukast sodium coated with eudragit for chronotherapy: statistical optimization, in vitro and in vivo evaluation[J]. Curr Drug Deliv, 2022, 19(10): 1047-1060. DOI: 10.2174/1567201819666220221091542.

25.Zheng Q, Ma D, Zhu Q, et al. Effect of azelastine hydrochloride combined with montelukast sodium in the treatment of patients with allergic rhinitis[J]. Am J Transl Res, 2021, 13(8): 9570-9577. https://pubmed.ncbi.nlm.nih.gov/34540080/.

26.Azizoglu E, Ozer O, Prausnitz MR. Fabrication of pure-drug microneedles for delivery of montelukast sodium[J]. Drug Deliv Transl Res, 2022, 12(2): 444-458. DOI: 10.1007/s13346-021-01047-9.

27.王震, 赵帅, 张利敏, 等. 运动训练对改善慢性阻塞性肺疾病症状的研究进展[J]. 解放军医学院学报, 2021, 42(12): 1330-1334. [Wang Z, Zhao S, Zhang LM, et al. Research progress on improving symptoms of chronic obstructive pulmonary disease through exercise training  [J]. Journal of PLA Medical College, 2021, 42(12): 1330-1334.] DOI: 10.3969/j.issn.2095-5227.2021.12.020.

28.Boswell-Ruys CL, Lewis CRH, Wijeysuriya NS, et al. Impact of respiratory muscle training on respiratory muscle strength, respiratory function and quality of life in individuals with tetraplegia: a randomised clinical trial[J]. Thorax, 2020, 75(3): 279-288. DOI: 10.1136/thoraxjnl-2019-213917.

29.程顺姣, 胡金英, 王凤玲, 等. 童趣化护理干预对支原体肺炎患儿的治疗效果的影响[J]. 医学临床研究, 2019, 36(7): 1386-1388. [Chen SJ, Hu JY, Wang FL, et al. Effect of kid-fun nursing intervention on the treatment of children with mycoplasma pneumonia[J]. Journal of Clinical Research, 2019, 36(7): 1386-1388.] DOI: 10.3969/ji.ssn.1671-7171.2019.00.000.

30.陶静, 韩雪婷. 呼吸功能训练对肺炎患儿康复效果的影响探讨[J]. 中国实用医药, 2020, 15(33): 173-175. [Tao J, Han X. Effect of respiratory function training on rehabilitation of children with pneumonia[J]. China Practical Medical, 2020, 15(33): 173-175.] DOI: 10.14163/j.cnki.11-5547/r.2020.33.078.

31.张洁, 金华, 顾岚, 等. 血清IL-17和IL-6及TNF-α与儿童特应性体质肺炎支原体感染的相关性[J]. 中华医院感染学杂志, 2020, 30(14): 2201-2205. [Zhang J, Jin H, Gu L, et al. The correlation between serum IL-17, IL-6, and TNF-α with Mycoplasma pneumoniae infection in children with atopic constitution[J]. Chinese Journal of Nosocomiology, 2020, 30(14): 2201-2205.] DOI: 10.11816/cn.ni.2020-192037.

32.任凌鹤. 个性化康复辅导干预在重症肺炎患儿中的应用[J]. 临床医学工程, 2020, 27(12): 1689-1690. [Ren  LH. Application of individualized rehabilitation counseling intervention in children with severe pneumonia[J]. Clinical Medicine Engineering, 2020, 27(12): 1689-1690.] DOI: 10.3969/j.issn.1674-4659.2020.12.1689.

33.王导新, 熊伟, 王勤, 等.《中国支气管哮喘防治指南（2020年版）》评述[J]. 西部医学, 2022, 34(1): 1-4. [Wang DX, Xiong W, Wang Q, et al. Commentary on "Chinese cuidelines for the prevention and treatment of bronchial asthma (2020 edition)"[J]. Medical Journal of West China, 2022, 34(1): 1-4.] DOI: 10.3969/j.issn.1672- 3511.2022.01.001.